IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Lrig1 marks a distinct population of stem cells restricted to the upper pilosebaceous unit in normal epidermis. Here we report that IL-17A–mediated activation of EGFR plays a critical role in the expansion and migration of Lrig1+ stem cells and their progenies in response to wounding, thereby promoting wound healing and skin tumorigenesis. Lrig1-specific deletion of the IL-17R adaptor Act1 or EGFR in mice impairs wound healing and reduces tumor formation. Mechanistically, IL-17R recruits EGFR for IL-17A–mediated signaling in Lrig1+ stem cells. While TRAF4, enriched in Lrig1+ stem cells, tethers IL-17RA and EGFR, Act1 recruits c-Src for IL-17A–induced EGFR transactivation and downstream activation of ERK5, which promotes the expansion and migration of Lrig1+ stem cells. This study demonstrates that IL-17A activates the IL-17R–EGFR axis in Lrig1+ stem cells linking wound healing to tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6. TRAF4 is enriched in Lrig1+ stem cells. (A) Lrig1, EGFR, and TRAF4 expression in PSU and IFE in unchallenged skin. Paraffin sections of mouse ear were stained for EGFR, TRAF4, and Lrig1 (a–f). SG, sebaceous gland; JZ, junction zone; Bu, bulge. Quantification (g) of indicated cells over Lrig1+ cells in the PSU is presented. n = 15 hair follicles. Error bars represent ± SEM. Immunofluorescence staining for Lrig1 and TRAF4 was performed in dorsal skin (h). (B) Epidermal cells isolated from Lrig1CreERT2 mice sorted based on GFP (Lrig1) expression followed by Western blot analysis. Data are representative of three independent experiments. Normalized densitometric quantifications of p-IκBα are annotated above the blot. (C) Schematic diagram for data shown in D and E and Fig. S4 (F–I, a). Schematic summary of EGFR, Lrig1, TRAF4, and ΔNp63 expression pattern in IL-17A–injected skin (b). TAM, tamoxifen. (D and E) Ear and dorsal skin sections from indicated mice stained for Lrig1 (green) and TRAF4 (red; for ear [a–d] and dorsal skin [e–h]; D) or TRAF4 (green) and p63 (ΔNp63; red; for ear [a–d] and dorsal skin [e–h]; E). Representative PSU and adjacent IFE are shown. n = 5 mice per group. Data are representative of three independent experiments shown in D and E. Bars, 50 µm.](https://figures.cochat.ai/paper-figures/a8e1efd34bbc411b8cf90a7605aa45aa/il-17r-egfr-axis-links-wound-healing-to-tumorigenesis-in-lrig1-stem-cells-figure-6.jpg)

![Figure 8. TRAF4 tethers IL-17RA and EGFR through the TRAF domain. (A) A model for IL-17–induced IL-17R–EGFR complex formation. RA, IL-17RA; RC, IL-17RC; TK, tyrosine kinase domain; TM, transmembrane domain. (B) TRAF4-inducible HeLa clones were transfected with indicated plasmids, followed by induction of TRAF4 expression. Protein–protein interactions were detected by PLA (red dots). Graph represents mean percentage of PLA-positive cells from 10 fields. Error bars represent ± SEM. Data are representative of at least three experiments. ***, P < 0.001, t test. Bar, 50 µm. (C and D) IL-17RA-KO HeLa cells were transfected with indicated plasmids followed by coimmunoprecipitation. Deleted regions in mutant protein are shown in A. (E and F) EGFR-deficient HeLa cells were transfected with indicated plasmids and subjected to coimmunoprecipitation. Deleted regions in mutant protein are shown in A. (G) IL-17RA was cotransfected with EGFR (with/without pretreatment of gefitinib, EGFRi), kinase dead EGFR (D813N), or the extracellular domain deletion mutant (ΔExtra1-600) into EGFR-deficient HeLa cells with overexpression of TRAF4. Cell lysates were immunoprecipitated with anti-HA (EGFR), followed by Western blot analysis. (H) TRAF4-deficient HeLa cells were transfected with indicated TRAF4 plasmids (ΔRing, ΔZincFinger [ZF], and ΔTRAF) followed by coimmunoprecipitation. (I) TRAF4-deficient HeLa cells were transfected with the indicated plasmids followed by coimmunoprecipitation. (J) Structure–function analysis of TRAF4 for its ability to promote IL-17RA–EGFR interaction. All data are representative of three independent experiments shown in C–J. WCL, whole cell lysate; IP, immunoprecipitation. (K and L) Pull-down experiments with recombinant IL-17RA, TRAF4, and EGFR proteins. Data are representative of three independent pull-down experiments.](https://figures.cochat.ai/paper-figures/9dd02664fd08446c9e919ecceebc76b1/il-17r-egfr-axis-links-wound-healing-to-tumorigenesis-in-lrig1-stem-cells-figure-8.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is evidence for physical and functional interactions with members of the FGFR and EGFR families as well”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Chen et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At least part of these skin healing events are mediated through IL-17 induction of anti-microbial protein REG3A in keratinocytes to promote their proliferation following injury”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Chen et al., 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“this pro-proliferative role likely contributes to the pathogenic effects of IL-17 in psoriasis, as well as potentially in skin cancer”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Chen et al., 2019
The cited source says what the claim attributes to it.
In the citing paper
“In addition, as discussed above, IL-17 promotes proliferation of skin epithelial cells to promote tumorigenesis”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Chen et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
Madisen, L., Zwingman, T. A., Sunkin, S. M., Oh, S. W., Zariwala, H. A., Gu, H., Ng, L. L., Palmiter, R. D., Hawrylycz, M. J., Jones, A. R., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2467 · Cited by 6,907
Identification of stem cells in small intestine and colon by marker gene Lgr5
Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J., et al. (2007) · Nature · doi:10.1038/nature06196 · Cited by 5,687 · cited 2×
“, 2010), and Lgr5-EGFP-ires-CreERT2 (labeled as Lgr5CreERT2; Barker et al., 2007) mice were purchased from The Jackson Laboratory.”
MethodImproved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“Although it has long been suggested that “tumor production is a possible overhealing” (Haddow, 1972; Dvorak, 1986), our understanding of how aberrant tissue repair leads to tumor formation continues to evolve.”
BackgroundCohen, S. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83739-0 · Cited by 2,193
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997 · cited 1×
“, 2013), anti–IL-17A antibody (Cosentyx; Novartis) is highly efficacious in treating psoriasis (Langley et al., 2014; Blauvelt et al., 2017), an inflammatory skin disease due to excessive hyperproliferation of keratinocytes (Bata-Csörgö and Szell, 2012).”
BackgroundInterleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R., Modrusan, Z., Ghilardi, N., de Sauvage, F. J., et al. (2008) · Nature Medicine · doi:10.1038/nm1720 · Cited by 1,921
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475 · cited 10×
“In line with this observation, Lrig1-specific IL-17RC deficiency also significantly reduced the DMBA/TPA-induced tumorigenesis (Fig.”
BackgroundInfluential
Cited by
Items 101–113 of 113
The roles of MCPyV early region in IL-17A-mediated inflammation and autophagy
Miao, J. (2021) · theses.fr (ABES) · doi:10.70675/0ed263f9za522z491ezb888z3d6d2826cd2b
Ricardo, J. W., Oscherwitz, M. E., Read, M. H., Wiater, A. H., Kontzias, C. L., Cleland, J. B., Wang, Y., & Jorizzo, J. L. (2025) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754251324945
Zhang, R., Chen, K., Gong, C., Wu, Z., Xu, C., Li, X.-N., Zhao, F., Wang, D., Cai, J., Zhou, A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24002882
Self-citationBonavina, G., Mamillapalli, R., Krikun, G., Zhou, Y., Gawde, N., & Taylor, H. S. (2024) · Figshare · doi:10.6084/m9.figshare.25734520
Bonavina, G., Mamillapalli, R., Krikun, G., Zhou, Y., Gawde, N., & Taylor, H. S. (2024) · Figshare · doi:10.6084/m9.figshare.25734686
Zhang, R., Chen, K., Gong, C., Wu, Z., Xu, C., Li, X.-N., Zhao, F., Wang, D., Cai, J., Zhou, A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24002879
Self-citationBonavina, G., Mamillapalli, R., Krikun, G., Zhou, Y., Gawde, N., & Taylor, H. S. (2024) · Figshare · doi:10.6084/m9.figshare.26714728
Zhang, R., Chen, K., Gong, C., Wu, Z., Xu, C., Li, X.-N., Zhao, F., Wang, D., Cai, J., Zhou, A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24002885
Self-citation創傷治癒における皮膚幹細胞の系譜細胞は毛包の発生を停止させながら表皮下水疱を治癒させる
藤村, 悠. (2021) · Institutional Repositories DataBase (IRDB) · doi:10.14943/doctoral.k14710
尋常性乾癬患者のケブネル現象には、表皮細胞の創傷によるEGFR-ERK/JNK-CCL20経路の活性化が寄与すると思われる
Furue, K. (2021) · Institutional Repositories DataBase (IRDB)
Razzaq, A., Sardar, M., Mushtaq, M., Nur‐e‐Alam, M., Ghayur, M. N., & Ul‐Haq, Z. (2026) · PLoS ONE · doi:10.1371/journal.pone.0361876
Mimpen, J. Y., Snelling, S. J. B., and, A. J. C., & Dakin, S. G. (2021) · doi:10.3389/fbioe.2021.795830.s001
Metadata
- Authors
- Chen, X., Cai, G., Liu, C., Zhao, J., Gu, C., Wu, L., Hamilton, T. A., Zhang, C.-J., Ko, J., Zhu, L., Qin, J., Vidimos, A., Koyfman, S., Gastman, B. R., Jensen, K. B., & Li, X.
- Affiliations
- Cleveland Clinic (US)
- University of Copenhagen (DK)
- Corresponding author
- Li, Xiaoxia
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2018-12-21
- Volume
- 216
- Issue
- 1
- Pages
- 195-214
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC6314525
- OpenAlex
- W2905823481
- Cited by
- 106
- References
- 66
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 15 · 2023: 19 · 2022: 17 · 2021: 20 · 2020: 17 · 2019: 8
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (5P01CA062220, 5P01 HL103453)
- National Institutes of Health Shared Instrumentation Grant (S10-OD019972)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Keywords
- IL-17A, IL-17 receptor, EGFR, Lrig1, epidermal stem cells, wound healing, skin carcinogenesis, Act1, TRAF4, Src kinase, ERK5, EGFR transactivation, stem cell migration, pilosebaceous unit
- MeSH terms
- CSK Tyrosine-Protein Kinase, Animals, Epidermis, HeLa Cells, Humans, Membrane Glycoproteins, Nerve Tissue Proteins, Stem Cells, Wound Healing, Signal Transduction, Mice, Knockout, src-Family Kinases, Adaptor Proteins, Signal Transducing, Mice, Receptors, Interleukin-17, Carcinogenesis, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.